These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26386037)

  • 1. Pillars Article: Peculiar Immunobiology of Bone Marrow Allografts: II. Rejection of Parental Grafts by Resistant FI Hybrid Mice. J Exp Med. 1971. 134: 1513-1528.
    Cudkowicz G; Bennett M
    J Immunol; 2015 Oct; 195(7):2946-61. PubMed ID: 26386037
    [No Abstract]   [Full Text] [Related]  

  • 2. Pillars Article: Peculiar Immunobiology of Bone Marrow Allografts: I. Graft Rejection by Irradiated Responder Mice. J Exp Med. 1971. 134: 83-102.
    Cudkowicz G; Bennett M
    J Immunol; 2015 Oct; 195(7):2926-45. PubMed ID: 26386036
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone Marrow Cell Rejection, MHC, NK Cells, and Missing Self Recognition: Ain't That Peculiar (with Apologies to Marvin Gaye).
    Raulet DH
    J Immunol; 2015 Oct; 195(7):2923-5. PubMed ID: 26386035
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice.
    Cudkowicz G; Bennett M
    J Exp Med; 1971 Dec; 134(6):1513-28. PubMed ID: 4942407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. 1986.
    Kärre K; Ljunggren HG; Piontek G; Kiessling R
    J Immunol; 2005 Jun; 174(11):6566-9. PubMed ID: 15905492
    [No Abstract]   [Full Text] [Related]  

  • 8. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
    Dennert G; Anderson CG; Warner J
    J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that active suppression contributes to the success of H-2-incompatible orthotopic corneal allografts in mice.
    Sonoda Y; Ksander B; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1374-6. PubMed ID: 8442147
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract]   [Full Text] [Related]  

  • 11. Orthotopic bone transplantation in mice. II. Studies of the alloantibody response.
    Halloran PF; Lee EH; Ziv I; Langer F; Gross AE
    Transplantation; 1979 Jun; 27(6):420-6. PubMed ID: 380081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts.
    Sentman CL; Kumar V; Koo G; Bennett M
    J Immunol; 1989 Mar; 142(6):1847-53. PubMed ID: 2646375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different sensitivities to hydrocortisone of natural killer cell activity and hybrid resistance to parental marrow grafts.
    Hochman PS; Cudkowicz G
    J Immunol; 1977 Dec; 119(6):2013-5. PubMed ID: 334980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection of marrow allografts: importance of H-2 homozygosity of donor cells.
    Bennett M
    Transplantation; 1972 Sep; 14(3):289-98. PubMed ID: 4404692
    [No Abstract]   [Full Text] [Related]  

  • 15. The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld.
    Milisauskas VK; Nakamura I
    Eur J Immunol; 1994 Feb; 24(2):336-42. PubMed ID: 8299682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination.
    Hisha H; Nishino T; Kawamura M; Adachi S; Ikehara S
    Exp Hematol; 1995 Apr; 23(4):347-52. PubMed ID: 7895782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histoincompatible skin and marrow grafts in mice given cholera toxin.
    Tsuru S; Taniguchi M; Shinomiya N; Takemura T; Togami M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1158-60. PubMed ID: 2650084
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha beta TCR+ T cells play a nonredundant role in the rejection of heart allografts in mice.
    Exner BG; Que X; Mueller YM; Domenick MA; Neipp M; Ildstad ST
    Surgery; 1999 Aug; 126(2):121-6. PubMed ID: 10455873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.